Skip to main content
Clinical Trials/NCT05075174
NCT05075174
Unknown
Not Applicable

Effect of Progesterone Levels on 15th Day After Embryo Transfer in Early Miscarriage < 7 WG or Evolving Pregancy Rates

University Hospital, Montpellier1 site in 1 country540 target enrollmentNovember 1, 2020
ConditionsART

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ART
Sponsor
University Hospital, Montpellier
Enrollment
540
Locations
1
Primary Endpoint
number of blood progesterone
Last Updated
4 years ago

Overview

Brief Summary

Progesterone level has been studied at days before embryo transfert. But, progesterone blood level has not been studied 15 days after embryo transfert. The aim of this study is to study progesterone level impact at 15 days after embryo transfert on evolving pregnanies or early miscarriages.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
June 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

number of blood progesterone

Time Frame: 1 day

blood progesterone at day 15 after embryo transfert

Study Sites (1)

Loading locations...

Similar Trials